Filing Details
- Accession Number:
- 0001209191-14-002700
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-01-09 18:27:54
- Reporting Period:
- 2014-01-08
- Filing Date:
- 2014-01-09
- Accepted Time:
- 2014-01-09 18:27:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1411158 | Anacor Pharmaceuticals Inc. | ANAC | Pharmaceutical Preparations (2834) | 251854385 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1105941 | P David Perry | C/O Anacor Pharmaceuticals, Inc. 1020 East Meadow Circle Palo Alto CA 94303 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-01-08 | 7,500 | $16.30 | 498,806 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-01-08 | 50,000 | $16.30 | 448,806 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-01-09 | 7,500 | $16.49 | 441,306 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopetd by the reporting person on November 19, 2013.
- The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $16.1200 to $16.4300, inclusive.
- The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $16.1200 to $16.4600, inclusive.
- The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $16.2200 to $16.9400, inclusive.